13F Holdings
中文EN

BG Bunge Global SA

Fats & Oils · NYSE · SEC CIK 1996862 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY55.5%
TTM net income YoY-12.4%
TTM EPS YoY-36.0%
Revenue 3-yr CAGR15.1%
Net income 3-yr CAGR-16.1%

Margins

Gross margin5.1%
Operating margin—
Net margin1.2%
FCF margin-2.8%
EBITDA margin—

Returns

ROE7.2%
ROA2.4%
ROIC (approx.)—
Asset turnover1.95x

Leverage & solvency

Liabilities / assets64.0%
Debt / equity1.03x
Current ratio1.50x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.82x
Accruals ratio4.4%
Payout ratio47.4%
Capex / revenue1.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$70.33B$53.11B$59.54B$67.23B$59.15B
Cost of revenue$66.92B$49.72B$54.70B$63.55B$55.79B
Gross profit$3.41B$3.39B$4.84B$3.68B$3.36B
R&D expense$28.00M$30.00M$35.00M$33.00M$33.00M
SG&A expense$2.11B$1.78B$1.72B$1.37B$1.23B
Interest expense$628.00M$471.00M$516.00M$403.00M$243.00M
Pretax income$1.13B$1.52B$3.05B$2.07B$2.56B
Income tax$288.00M$336.00M$714.00M$388.00M$398.00M
Net income$816.00M$1.14B$2.24B$1.61B$2.08B
EPS (basic)4.958.0915.0710.8314.50
EPS (diluted)4.917.9914.8710.5113.64
Dividends declared per share2.802.722.612.402.08
Weighted avg. shares (diluted)166.47M142.22M150.79M153.13M152.37M
Balance sheet
Cash & equivalents$1.14B$3.33B$2.60B$1.15B$905.00M
Short-term investments$861.00M$484.00M$105.00M$119.00M—
Receivables$3.87B$2.15B$2.59B$2.83B—
Inventory$13.20B$6.49B$7.11B$8.41B—
Current assets$24.39B$15.96B$16.35B$16.76B—
PP&E, net$11.68B$5.25B$4.54B$3.62B—
Goodwill$3.14B$453.00M$489.00M$470.00M—
Intangibles$309.00M$321.00M$398.00M$360.00M—
Total assets$44.53B$24.90B$25.37B$24.58B$23.82B
Current liabilities$15.13B$7.43B$7.69B$9.60B—
Short-term debt$5.22B$1.54B$802.00M$846.00M—
Long-term debt$8.83B$4.69B$4.08B$3.26B—
Total debt$14.05B$6.24B$4.88B$4.11B—
Total liabilities$27.11B$13.95B$13.56B$14.62B—
Shareholders' equity$15.90B$9.91B$10.85B$9.22B$7.83B
Net debt$12.92B$2.91B$2.28B$2.95B—
Cash flow statement
Operating cash flow$844.00M$1.90B$3.31B-$5.55B-$2.89B
Capital expenditure$1.72B$1.38B$1.12B$555.00M$399.00M
Free cash flow-$879.00M$524.00M$2.19B-$6.10B-$3.29B
Investing cash flow-$5.23B-$1.11B-$1.01B$6.50B$5.11B
Financing cash flow$2.23B-$90.00M-$856.00M-$769.00M-$1.63B
Depreciation & amortization$703.00M$468.00M$451.00M$408.00M$424.00M
Stock-based compensation$73.00M$65.00M$69.00M$65.00M$61.00M
Dividends paid$459.00M$378.00M$383.00M$349.00M$289.00M
Share buybacks$551.00M$1.10B$600.00M$200.00M$100.00M

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.